Investigating how RNA methylation affects heart failure progression
RNA methylation in the progress of heart failure
This study is looking at how changes to certain RNA molecules might affect heart health, especially in people with heart failure, to find new ways to help manage or prevent this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11046853 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of RNA methylation in cardiac fibrosis, a key factor in heart failure. It aims to explore how the modification of specific RNA molecules can influence the stability and function of genes involved in heart tissue repair and remodeling. By examining the molecular mechanisms that regulate the translocation of β-catenin, a protein linked to fibrosis, the study seeks to uncover new therapeutic targets for treating heart failure. Patients may benefit from insights gained into how to better manage or prevent heart failure through targeted therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults experiencing cardiac dysfunction or those at risk of developing heart failure.
Not a fit: Patients with heart failure due to non-cardiac causes or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or prevent the progression of heart failure.
How similar studies have performed: Other research has shown promising results in understanding RNA modifications in various diseases, suggesting potential for success in this area as well.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Verma, Suresh K — University of Alabama at Birmingham
- Study coordinator: Verma, Suresh K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.